InspireMD (NSPR) Capital Expenditures Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | 27.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.97% |
| Sep 30, 2025 | -21.85% |
| Jun 30, 2025 | 21.26% |
| Mar 31, 2025 | 84.10% |
| Dec 31, 2024 | 44.65% |
| Sep 30, 2024 | 338.54% |
| Jun 30, 2024 | 955.56% |
| Mar 31, 2024 | 680.00% |
| Dec 31, 2023 | 126.32% |
| Sep 30, 2023 | -57.52% |
| Jun 30, 2023 | -60.87% |
| Mar 31, 2023 | -32.43% |
| Dec 31, 2022 | -11.21% |
| Sep 30, 2022 | 43.95% |
| Jun 30, 2022 | 112.96% |
| Mar 31, 2022 | 42.31% |
| Dec 31, 2021 | 72.58% |
| Dec 31, 2020 | 16.98% |
| Dec 31, 2019 | 43.24% |
| Sep 30, 2019 | 3,200.00% |
| Jun 30, 2019 | 266.67% |
| Mar 31, 2019 | 6,500.00% |
| Dec 31, 2018 | 76.19% |
| Sep 30, 2018 | -97.26% |
| Jun 30, 2018 | 145.45% |
| Mar 31, 2018 | -99.35% |
| Dec 31, 2017 | -41.67% |
| Sep 30, 2017 | 3,550.00% |
| Dec 31, 2016 | 800.00% |
| Mar 31, 2015 | -92.31% |
| Mar 31, 2014 | -58.06% |
| Sep 30, 2013 | 128.57% |
| Mar 31, 2013 | -60.76% |
| Dec 31, 2012 | -46.39% |
| Sep 30, 2012 | -37.50% |
| Mar 31, 2012 | 182.14% |
| Dec 31, 2011 | 470.59% |
| Sep 30, 2011 | 250.00% |